Kaixin Holdings Announces Receipt of Nasdaq Letter Regarding Regaining Compliance with Minimum Bid Price Requirement

Stock Information for Channel Therapeutics Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Channel Therapeutics Corporation

Kaixin Holdings Announces Share Consolidation
Kaixin Holdings Announces Intended Acquisition of Honglu Technology to Optimize AI Applications
Kaixin Holdings Establishes Digital Asset Management Department and Launches Digital Asset Allocation Strategy
Kaixin Holdings Announces Annual General Meeting Results
Kaixin Holdings Announces Acquisition of XINGCAN, Launching AI Education Business
Kaixin Holdings Explores Strategic Alternatives with Potential Acquisition in Crypto Mining Sector
Kaixin Holdings Announces Share Consolidation
Kaixin Holdings Announces Extraordinary General Meeting Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.